Akcea Therapeutics, Inc.

Swiss National Bank

Report date

9/30/2020

Quarter

2020 Q3

Filed

11/9/2020

Shares

45,100

Value ($000)

818

Weight

0.0%

2019 Q4 - 2020 Q3 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q3	11/9/2020	818	0.0%	45,100	9/30/2020
2020 Q2	8/5/2020	618	0.0%	45,100	6/30/2020
2020 Q1	5/8/2020	521	0.0%	36,400	3/31/2020
2019 Q4	2/6/2020	603	0.0%	35,600	12/31/2019